Inviga

Inviga Trust (IN/AIF2/22-23/1227) is a SEBI-registered Category II AIF managed by Inviga Investment Advisors Private Limited. Inviga Investment Advisors is an India-based investment advisory firm specializing in the healthcare sector, founded in 2022, at WeWork Galaxy 43, Residency Road, Ashok Nagar, Bengaluru – 560025. The fund's scheme is the Inviga Healthcare Fund. Inviga is developing a differentiated multi-specialty hospital platform while strategically investing in high-potential healthcare and life sciences ventures. Through its dual-track strategy of majority-led hospital roll-ups and minority investments in innovative, IP-driven enterprises, Inviga aims to accelerate scalable healthcare solutions and long-term value creation across the ecosystem. Portfolio: Forus Health (21% stake acquisition — leading ophthalmic technology company, 3nethra AI-driven diagnostic devices, 22M+ patients screened across 75 countries; recognised by TIME Magazine's World's Top 400 HealthTech Companies).

Inviga's investment strategy combines two tracks: (1) Majority-led hospital roll-ups — building a differentiated multi-specialty hospital platform across India; (2) Minority investments in innovative, IP-driven healthcare and life sciences enterprises. The dual-track approach aims to create sustainable healthcare value at scale: the hospital platform provides operational infrastructure while venture-style minority investments in healthtech and life sciences companies provide innovation exposure. Inviga is particularly focused on companies using AI and technology to improve diagnostics accessibility and patient outcomes.